Cryptococcosis is a fungal disease.It is caused by Cryptococcus neococcus, or Cryptococcus gattii.The disease is spread by inhaling a fungus linked to birds.It can infect animals and humans.It infects humans by inhaling fungus.The fungus mainly affects the lungs, but it can spread to the brain, called meningitis.Symptoms of the disease include - fever, headache, fatigue, dry cough and blurred vision.It can be treated by dozing off with amphotericin B, fluorocytosine and fluconazole.
This report contains market size and forecasts of Cryptococcosis Drugs in Global, including the following market information:
Global Cryptococcosis Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cryptococcosis Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Amphotericin B Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cryptococcosis Drugs include Abbott, Pfizer, Bristol-Mayers Squibb, Sigmapharm Laboratories, Novartis and Glenmark Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cryptococcosis Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cryptococcosis Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cryptococcosis Drugs Market Segment Percentages, by Type, 2021 (%)
Amphotericin B
Flucytosine
Fluconazole
Others
Global Cryptococcosis Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cryptococcosis Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacy
Retail Pharmacies
Other
Global Cryptococcosis Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cryptococcosis Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cryptococcosis Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cryptococcosis Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Pfizer
Bristol-Mayers Squibb
Sigmapharm Laboratories
Novartis
Glenmark Pharmaceuticals